The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE EFFECT OF NICOTINIC ACID IN STUPOR, LETHARGY AND VARIOUS OTHER PSYCHIATRIC DISORDERS

Published Online:https://doi.org/10.1176/ajp.98.1.83

Thirty-eight patients in stuporous states or in active psychoses without evident cause showed prompt and often very impressive improvement after treatment with nicotinic acid.

The usual criteria for the clinical diagnosis of pellagra or of other deficiency syndromes were absent.

This experience leads us to believe that many patients whose psychiatric status suggests the diagnosis of toxic psychosis or exhaustion delirium may be relieved of their symptoms by the administration of nicotinic acid. It is believed that in such cases and in cases who show unexplained clouding of consciousness a therapeutic trial of nicotinic acid is the only means available by which one can determine whether or not the psychosis is due to avitaminosis.

In some exceptional cases, even when clinical evidence of pellagra is absent, extremely large amounts of nicotinic acid are necessary to obtain satisfactory results.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.